Numerous studies [27] indicate that excessive activation of the Kynurenine Pathway (KP) is widely observed in lung cancer, gastrointestinal cancer, prostate cancer, glioma, melanoma, and pancreatic cancer, with a marked upregulation of IDO1, correlating with poor tumor prognosis. Here, IDO1 is linked to neoplasm.